BCR and chronic myelogenous leukemia, BCR-ABL1 positive: In chronic myelogenous leukemia (CML), a genetic change leads to the fusion of the bcr and abl genes, which together encode for a cytoplasm-targeted deregulated form of Abl tyrosine kinase, which is responsible for the development of CML.